GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK) is a publicly traded Healthcare sector company. As of May 20, 2026, GSK trades at $50.78 with a market cap of $100.90B and a P/E ratio of 0.00. GSK moved -0.54% today. Year to date, GSK is +2.86%; over the trailing twelve months it is +34.48%. Its 52-week range spans $31.72 to $61.70. Analyst consensus is neutral with an average price target of $54.00. Rallies surfaces GSK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own GSK include Bridgewater Associates. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for GSK plc American Depositary Shares (Each representing two Ordinary Shares).
| Metric | Value |
|---|---|
| Price | $50.78 |
| Market Cap | $100.90B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.46% |
| 52-Week High | $61.70 |
| 52-Week Low | $31.72 |
| Volume | 2.56M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover GSK: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $54.00.